Twitter | Search | |
Search Refresh
Andy Biotech Dec 16
Anti-BCMA ADC pivotal data out 31% ORR 3% CR 27% Gr3/4 keratopathy Very hard to see how this risk/benefit profile can be competitive in the super crowded BCMA space. No wonder this data couldn't get into LBA.
Reply Retweet Like
Raul Cordoba, MD, PhD Mar 26
Reply Retweet Like
Michael Makris Jan 6
Important article for anyone interested in gene therapy and missed the Sabatino presentation at . Anybody opting for gene therapy should read this. Long term safety of AAV gene therapy is unknown.
Reply Retweet Like
Stephanie Lee, MD Dec 11
My first tweet ever, to start sharing what it’s like to be the 2020 ASH President. Thanks for the kind words! Tweets will start in the New Year.
Reply Retweet Like
Surviving Myeloma Dec 17
Reply Retweet Like
Myeloma Crowd Jan 16
Amazing summary by patient advocate Jack Aiello (). Thank you Jack for sharing!
Reply Retweet Like
Chimeric Antigen Receptor T-Cell (CAR-T) Dec 25
Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities
Reply Retweet Like
chadi nabhan MD, MBA, FACP Dec 25
Four cycles of R-CHOP are sufficient for favorable prognosis , but I am not sure that the 2 additional doses of rituximab add anything. Based on recent data, likely can be safely omitted?
Reply Retweet Like
VJHemOnc May 2
Reply Retweet Like
Genentech Dec 17
Apoptosis, or cellular self-destruction, is how our body rids itself of cells that are damaged, infected or mutated. Read "Turning a New Leaf" to learn how a family of proteins can trigger cancer cells to self-destruct.
Reply Retweet Like
Medscape Jan 8
Lymphoma is now curable but its pricey. 💲 💲
Reply Retweet Like
Michel Doepke Dec 13
CMO interview about the latest data at , the next steps and upcoming catalysts.
Reply Retweet Like
Jerlym Porter PhD Dec 10
Reply Retweet Like
Rafael Fonseca MD Dec 14
WHAT IS THE RISK CLASSIFICATION OF THE t(11;14) in MM? This has been a long-debated question and probably asked in the wrong way. I have always had a special interest in the t(11;14) and want to tell a story and how it relates to venetoclax. 1/x
Reply Retweet Like
Anas Younes, M.D. Dec 15
If you missed , you can get all the updates by attending our 5TH lymphoma symposium on May 2-3, 2020 in New York. You can use this link to review the program and register
Reply Retweet Like
Mohamad Mohty Jan 7
What is the value of testing in & what does it mean for pts? Watch doc to hear from experts inc. & 👉 👈
Reply Retweet Like
Myeloma Crowd Dec 27
What is double hit myeloma? Learn more from Dr. Martin Kaiser at
Reply Retweet Like
National Cancer Institute Jan 14
Immunotherapy drug improves outcomes for some children with relapsed leukemia
Reply Retweet Like
Katherine Antel Dec 10
Incredible. Subtyping DLBCL from the plasma...
Reply Retweet Like
Michelle Lavin Dec 11
Heartwarming welcome back home from to Ireland from the lovely childrens choir in T2 Jingle bells in Irish (Bualadh bos as Gaeilge) Great to be home, cant help getting in Christmas spirit seeing this after a long overnight flight ☘🎅
Reply Retweet Like